MAX-40279
CAS No. | 2070931-57-4 | Cat. No. | BCP46002 |
Name | MAX-40279 | ||
Synonyms | MAX 40279; MAX40279; | ||
Formula | C22H23FN6OS | M. Wt | 438.52 |
Description | FLT3/FGFR Dual Kinase Inhibitor MAX-40279 is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) and FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2), with potential antineoplastic activity. Upon oral administration of FLT3/FGFR dual kinase inhibitor MAX-40279, this agent binds to and inhibits both FGFR and FLT3, including FLT3 mutant forms, which results in the inhibition of FGFR/FLT3-mediated signal transduction pathways. This inhibits proliferation in FGFR/FLT3-overexpressing tumor cells. FGFR, a family of receptor tyrosine kinases, is upregulated in many tumor cell types. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias. They both play key roles in cellular proliferation and survival. | ||
Related Products | 2388506-44-1(MAX-40279 hemiadipate ) 2388506-43-0(MAX-40279 hemifumarate) | ||
Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
Targets | FLT3 FGFR |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.